Skip to content

Upstate New York Infant Development Screening Program

Upstate New York Infant Development Screening Program

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03106493
Acronym
Upstate KIDS
Enrollment
6171
Registered
2017-04-10
Start date
2008-07-01
Completion date
2019-11-30
Last updated
2021-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergies, Asthma, Blood Pressure, Developmental Delay, Motor Delay, Obesity

Brief summary

The goal of the Upstate KIDS Study is to track the growth, development and long-term health of children given the increasing use of infertility treatment, occurrence of maternal obesity and pregnancy complications, and rising maternal age at birth.

Detailed description

The Upstate KIDS Study aims to determine if there are differences in health measures between children conceived by infertility treatment and children conceived naturally. In the first phase of the study, the focus was on growth and development through age 3 years. In the second phase of the study, the focus is turning to cardiometabolic factors through age 9 years. Infertility treatments include assisted reproductive technologies (ART) such as in vitro fertilization (IVF), controlled ovarian hyperstimulation (COH) and ovulation induction (OI). The study was originally designed as a matched exposure cohort. Specifically, singletons whose birth certificates indicated the use of infertility treatment were considered 'exposed' singleton infants and subsequently frequency-matched on perinatal region of birth at a ratio of 1:3 to 'unexposed' singletons. Twins and higher order multiples were invited to participate regardless of mode of conception. Mothers and their newborns were recruited approximately 2-4 months postpartum. The first phase of the study was completed in 2014 and main findings can be found under publications. The second phase objectives are: To determine whether infertility treatment is associated with differences in growth and development from age 6 to 8 years with particular focus on childhood cardio-metabolic outcomes by follow-up of children conceived by ART or other infertility treatments and children who were conceived without treatment. Secondarily, to assess epigenetic differences as measured by DNA methylation using collected biospecimens.

Interventions

None (observational)

Sponsors

New York State Department of Health
CollaboratorOTHER_GOV
University at Albany
CollaboratorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Lead SponsorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Mothers delivering a live birth in New York State (excluding New York City).

Exclusion criteria

* Refused follow-up

Design outcomes

Primary

MeasureTime frameDescription
Blood PressureThrough age 9 yearsMeasurement of blood pressure

Secondary

MeasureTime frameDescription
Motor milestone development4-24 monthsStudy collected information using questionnaires to mothers with aid of journal

Other

MeasureTime frameDescription
Breastfeeding information4-12 monthsStudy collected information using questionnaires to mothers

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 20, 2026